Company / Free Cash Flow
RHYTHM PHARMACEUTICALS, INC. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$116.6M
FY2025
5-year range
-$173.7M / -$113.9M
FY2021-FY2025
Trend
-2.4%
vs FY2024
Sector context
#114 of 194
Health Care
What the data says
At -$117M, RHYTHM PHARMACEUTICALS, INC.'s free cash flow ranks #114 of 194 in the Health Care sector. Free Cash Flow has fluctuated over the past 10 years, ranging from -$174M in FY2022 to -$24M in FY2016.
Based on SEC 10-K filings.
-$117M in FY2025.
Improved from -$136M to -$117M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#114 of 194 in Health CareTop 59% of 194This company -$116.6M Sector average $470.6M
▼
-124.8% below sector average
Key checks
Key Insights
- In FY2025, free cash flow decreased 2.4% year-over-year.
- Ranks #114 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2016.
- Lowest free cash flow in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -2.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$116.6M | -2.4% |
| FY2024 | -$113.9M | +16.4% |
| FY2023 | -$136.2M | +21.6% |
| FY2022 | -$173.7M | -18.6% |
| FY2021 | -$146.4M | -19.8% |
| FY2020 | -$122.2M | +3.1% |
| FY2019 | -$126.1M | -100.9% |
| FY2018 | -$62.8M | -112.1% |
| FY2017 | -$29.6M | -21.9% |
| FY2016 | -$24.3M | -247.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026